HBANP Stock News 1,299.98 05/13/2014 14:59:15 Huntington Bancshares

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Taipei's Headliners at AUTOMATE: Smart and Strategic Alright, let's cut to the chase—New Taipei City is making some serious moves at AUTOMATE 2026 over in Chicago. We're not just talking about a few Taiwanese companies patting themselves on the back; we're talking precision manufacturing, cutting-edge industrial AI, and a bold face-off with global heavyweights. Pull up...

Exploring the Future of the S&P 500 Rally In recent weeks, the S&P 500 has reached new highs, sparking discussions about its potential for further growth. Experts suggest that there's still considerable room for the index to rally despite its recent performance, particularly because many institutional investors have not fully participated in this upward movement. Market...

Getty Images to Provide Unmatched Visual Coverage at the Olympics Getty Images, recognized globally for their captivating visual content, is preparing to offer exceptional photography services during the upcoming Milano Cortina 2026 Olympic Winter Games. As the Official Photographic Agency of the International Olympic Committee, they are entrusted with the vital role of...

AECOM Takes Strategic Steps with New Leadership Appointments AECOM, a leader in global infrastructure, has announced significant leadership changes aimed at fortifying its operations and enhancing service delivery to clients. The appointments of Bane Gaiser, Richard Whitehead, and Sam Donelson underscore AECOM's commitment to leveraging internal talent and expertise. Each...

Cielo Waste Solutions Finalizes Successful Unit Offering Cielo Waste Solutions Corp. (TSXV: CMC; OTC PINK: CWSFF) has accomplished a significant milestone in its funding strategy by closing the second and final tranche of its non-brokered private placement offering. This closing marks a crucial step for Cielo, which is dedicated to transforming waste into valuable...